Finoriq research workspace
Cencora, Inc. (COR) SEC Filings & Filing Highlights
Cencora, Inc. sources and distributes pharmaceutical products in the United States. Review COR SEC filings, filing highlights, and disclosure activity on Finoriq.
Company Snapshot
Cencora, Inc. sources and distributes pharmaceutical products in the United States and internationally. The company's U.S. Healthcare Solutions segment distributes generic and injectable pharmaceuticals, over-the-counter healthcare products, home healthcare supplies and equipment, and related services to acute care hospitals and health systems, independent and chain retail pharmacies, mail order pharmacies, medical clinics, long-term care and alternate site pharmacies, and other customers; distributes plasma and other blood products, vaccines, and other specialty pharmaceutical products; provides pharmacy management, staffing, and other consulting services; supply management software to retail and institutional healthcare providers; packaging solutions to institutional and retail healthcare providers; clinical trial support, product post-approval, and commercialization support services; data analytics, outcomes research, and other services for biotechnology and pharmaceutical manufacturers; pharmaceuticals, vaccines, parasiticides, diagnostics, micro feed ingredients, and other products to the companion animal and production animal markets; sales force services to manufacturers; and offers other services to physicians who specialize in various disease states, such as oncology, as well as to other healthcare providers, including hospitals and dialysis clinics. Its International Healthcare Solutions segment provides international pharmaceutical wholesale and related service, and global commercialization services; distributes pharmaceuticals, other healthcare products, and related services to pharmacies, doctors, health centers, and hospitals; and offers specialty transportation and logistics services for the biopharmaceutical industry. The company was formerly known as AmerisourceBergen Corporation and changed its name to Cencora, Inc. in August 2023. Cencora, Inc. was founded in 1871 and is headquartered in Conshohocken, Pennsylvania.
- Company
- Cencora, Inc. (COR)
- Ticker
- COR
- Market Cap
- $59.3B
- Latest Price
- $304.91
- Industry
- Other Pharmaceuticals
Cencora, Inc. (COR) Recent SEC Filing Highlights
Recent SEC filings, filing events, and disclosure highlights indexed for Cencora, Inc. (COR).
| Event | Form | Date |
|---|---|---|
| Cencora Announces Samantha Hammock as Chief Human Resources OfficerCencora Announces Samantha Hammock as Chief Human Resources Officer | 8-K7.01 | 2026-06-15 |
| On June 15, 2026, Cencora, Inc. (the “Company”) announced that Silvana Battaglia will retire as...On June 15, 2026, Cencora, Inc. (the “Company”) announced that Silvana Battaglia will retire as Executive Vice President and Chief Human Re... | 8-K5.02 | 2026-06-15 |
| Cencora Appoints Eva Boratto as Executive Vice President and Chief Financial OfficerCencora Appoints Eva Boratto as Executive Vice President and Chief Financial Officer | 8-K7.01 | 2026-05-29 |
| On May 27, 2026, Cencora, Inc. (the “Company”) announced that Eva C. Boratto has been appointed...On May 27, 2026, Cencora, Inc. (the “Company”) announced that Eva C. Boratto has been appointed Executive Vice President and Chief Financia... | 8-K5.02 | 2026-05-29 |
| CENCORA REPORTS FISCAL 2026 SECOND QUARTER RESULTSCENCORA REPORTS FISCAL 2026 SECOND QUARTER RESULTS | 8-K7.01 | 2026-05-06 |
Live data loads in the app
This static page shell gives search engines reliable page context. Current tables, filings, charts, and market data continue to load from Finoriq APIs after the application starts.